RYAN LITTLE: Open Payments
NPI 1215098025 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,844 in 212 payments from 25 companies in 2025. Trend: 2023 $3,236 · 2024 $4,125 · 2025 $4,844
Food & beverage: $4,844
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 9 | $951 |
| Novo Nordisk Inc | 26 | $565 |
| AstraZeneca Pharmaceuticals LP | 14 | $423 |
| ABBVIE INC. | 31 | $421 |
| GlaxoSmithKline, LLC. | 24 | $379 |
| Lilly USA, LLC | 17 | $305 |
| Exact Sciences Corporation | 8 | $238 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $238 |
| Amgen Inc. | 16 | $224 |
| ViiV Healthcare Company | 4 | $153 |
Products named: VRAYLAR, Wegovy, Ozempic, BREZTRI, CAPLYTA, JARDIANCE, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
